22nd Century Group Inc (XXII)

[Frenchy2016]

for the post.
I didn't know that part of the story (when I guess it all started)?
"It was then sublicensed to Vector Group Ltd. (NYSE:VGR), with the goal of the latter developing a brand (which it did, called Quest) of low nicotine cigarettes and carrying the brand through an FDA approval process so as to allow the company to market Quest as a smoking cessation product.
It didn't work out that way.
Vector conducted a Phase II study (results here) and then said it wasn't going to push for a Phase III. 22nd Century took Vector to court, got back the rights to the grow process and also won the rights to use the Vector-generated data in its own FDA submissions.